ReShape Lifesciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:RSLS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
31 May 24	SellUS$39	Thomas Stankovich	Individual		2.97	US$14.50

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 58.7%.

Top 13 shareholders own 7.71% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.38%	Yair Schneid	37,407	US$207.6k	-11.8%	no data
0.13%	Tower Research Capital Europe Limited	665	US$3.7k	321%	no data
0.12%	BlackRock, Inc.	588	US$3.3k	0.17%	no data
0.078%	Thomas Stankovich	393	US$2.2k	0%	no data
0.0028%	Dan Gladney	14	US$77.6	0%	no data
0.00079%	Bank of America Corporation, Asset Management Arm	4	US$22.2	33.3%	no data
0.00059%	Cornerstone Planning Group Inc.	3	US$16.6	50%	no data
0.00039%	Group One Trading LP, Asset Management Arm	2	US$11.0	100%	no data
0.0002%	CIBC Private Wealth Advisors, Inc.	1	US$5.6	0%	no data
0.0002%	UBS Asset Management AG	1	US$5.6	-99.9%	no data
0.0002%	Morgan Stanley, Investment Banking and Brokerage Investments	1	US$5.6	0%	no data
0.0002%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$5.6	0%	no data
0.0002%	Planned Solutions Financial & Insurance Services, Inc.	1	US$5.6	0%	no data